Entrusted by the State-owned Assets Supervision and Administration Commission (SASAC) of the State Council, China Resources Holdings undertakes the important task of establishing the platform of pharmaceutical industry, which is supported by central state-owned enterprises, and thus implementing the strategic reorganization of China Worldbest Group Co., Ltd. (CWGC) and 999 Group Co., Ltd.. CWGC is one of China's largest pharmaceutical enterprise groups, whose total sales revenue ranks the first in the national pharmaceutical industry, and whose exports take lead in China's pharmaceutical manufacturing enterprises. 999 Group is one of China's largest integrative pharmaceutical companies. China Resources (Holdings) Co., Limited holds 29.625% equities of Shandong Dong-E E-Jiao Ltd. ¨C an A-share listed company in Mainland, making it the single largest shareholder of the latter. China Resources strives to establish a competitive high-level platform for national pharmaceutical industry.